I have a patient who had a failed mesh placement and a panniculectomy and who has developed at least three separate fistulas with a very large amount of output (3-4 L/24 hrs). Any suggestions? I am using an Eakin wound management pouch hooked up to wall suction.
Skin substitute company outlines strategic growth plan
- Thu, 10/15/09 - 10:54am
- 0 Comments
- 1233 reads
Advanced BioHealing Inc (Westport, CT) announced a strategic growth plan designed to continue to transform the company into a leading international regenerative medicine company. The company manufactures and markets Dermagraft®, a bioengineered skin substitute that repairs tissue damage caused by disease or injury and supports the body’s natural healing process in patients with diabetic foot ulcers. To spur future growth, executive management has outlined a growth strategy to leverage current successes, develop its international presence, address new applications, and expand its product line; three key goals include continuing the expansion of company sales, extending product use for multiple indications, and diversifying the product portfolio.
The company continues to build its sales and marketing infrastructure by recruiting top sales professionals from inside the pharmaceutical and medical device industries. The company also is working with industry peers to promote regulatory, research, and reimbursement policies that foster innovation in regenerative medicine and educate at-risk populations of senior citizens and patients suffering with diabetes. A corporate identity program designed to position the company as a leading regenerative medicine company complete with new logo, tagline, web site, and public relations campaign are now in place.
For more information, visit www.Dermagraft.com.
